13F HOLDINGS REPORT
Finepoint Capital LP
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0000904454-24-000600
Total Value
$1.38B
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | QXO INC | QXO-PB | 25,750,781 | $406.1M | 29.51% |
| 2 | SPDR S&P 500 ETF TR | SPY | 555,000 | $318.4M | 23.14% |
| 3 | ISHARES TR | 464287655 | 1,065,000 | $235.2M | 17.10% |
| 4 | Liberty Broadband Corp | LBRDP | 1,994,510 | $154.2M | 11.20% |
| 5 | REVOLUTION MEDICINES INC | RVMDW | 731,960 | $33.2M | 2.41% |
| 6 | Argenx SE | ARGX | 54,428 | $29.5M | 2.14% |
| 7 | ASCENDIS PHARMA A/S | ASND | 190,072 | $28.4M | 2.06% |
| 8 | TRAVERE THERAPEUTICS INC | TVTX | 1,782,267 | $24.9M | 1.81% |
| 9 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 650,852 | $20.9M | 1.52% |
| 10 | MoonLake Immunotherapeutics | MLTX | 388,835 | $19.6M | 1.42% |
| 11 | SAREPTA THERAPEUTICS INC | SRPT | 133,535 | $16.7M | 1.21% |
| 12 | GALAPAGOS NV | GLPGF | 557,762 | $16.1M | 1.17% |
| 13 | ARVINAS INC | ARVN | 574,378 | $14.1M | 1.03% |
| 14 | ACADIA PHARMACEUTICALS INC | ACAD | 905,384 | $13.9M | 1.01% |
| 15 | CYTOKINETICS INC | CYTK | 256,449 | $13.5M | 0.98% |
| 16 | RELAY THERAPEUTICS INC | RLAY | 1,626,146 | $11.5M | 0.84% |
| 17 | PROTHENA CORP PLC | PRTA | 433,471 | $7.3M | 0.53% |
| 18 | SOLID BIOSCIENCES INC | SLDB | 961,251 | $6.7M | 0.49% |
| 19 | EYEPOINT PHARMACEUTICALS INC | EYPT | 707,404 | $5.7M | 0.41% |
| 20 | Swiftmerge Acquisition Corp | G63836111 | 490,000 | $39,200 | 0.00% |
| 21 | Compass Digital Acquisition Corp | COMP | 459,906 | $28,054 | 0.00% |
| 22 | MONEYHERO LIMITED | MNYWW | 895,000 | $26,850 | 0.00% |
| 23 | Marblegate Acquisition Corp | 56608A113 | 735,000 | $25,284 | 0.00% |
| 24 | LAKESHORE BIOPHARMA CO LTD | G9845F117 | 489,999 | $24,206 | 0.00% |
| 25 | CALIDI BIOTHERAPEUTICS INC | CLDWW | 12,500 | $14,249 | 0.00% |
| 26 | CALIDI BIOTHERAPEUTICS INC | CLDWW | 655,200 | $8,583 | 0.00% |